Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Vet Res ; 48(1): 78, 2017 11 21.
Article in English | MEDLINE | ID: mdl-29157309

ABSTRACT

Hepatitis E virus (HEV) causes self-limiting acute hepatitis in humans that can eventually result in acute liver failures or progress to chronic infections. While in tropical and sub-tropical areas, HEV infections are associated with important waterborne epidemics, in Northern countries, HEV infections are autochthonous with a zoonotic origin. In the past decade, it has become clear that certain HEV genotypes are zoonotic and that swine, and more generally Suidae, are the main reservoir. Zoonotic transmissions of the virus may occur via direct contact with infected pigs, wild boars or consumption of contaminated meat. This review describes the current knowledge on domestic and wild Suidae as reservoirs of HEV and the evidence of the different routes of HEV transmission between these animals and humans.


Subject(s)
Disease Reservoirs/veterinary , Food/virology , Hepatitis E virus/physiology , Hepatitis E/veterinary , Swine Diseases/transmission , Zoonoses/transmission , Animals , Animals, Domestic , Animals, Wild , Disease Reservoirs/virology , Hepatitis E/transmission , Hepatitis E/virology , Humans , Swine , Swine Diseases/virology , Zoonoses/virology
2.
J Virol ; 88(18): 10792-802, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25008919

ABSTRACT

UNLABELLED: Bluetongue virus (BTV) is a double-stranded RNA (dsRNA) virus that causes an economically important disease in ruminants. BTV infection is a strong inducer of type I interferon (IFN-I) in multiple cell types. It has been shown recently that BTV and, more specifically, the nonstructural protein NS3 of BTV are able to modulate the IFN-I synthesis pathway. However, nothing is known about the ability of BTV to counteract IFN-I signaling. Here, we investigated the effect of BTV on the IFN-I response pathway and, more particularly, the Janus tyrosine kinase (JAK)/signal transducer and activator of transcription protein (STAT) signaling pathway. We found that BTV infection triggered the expression of IFN-stimulated genes (ISGs) in A549 cells. However, when BTV-infected cells were stimulated with external IFN-I, we showed that activation of the IFN-stimulated response element (ISRE) promoter and expression of ISGs were inhibited. We found that this inhibition involved two different mechanisms that were dependent on the time of infection. After overnight infection, BTV blocked specifically the phosphorylation and nuclear translocation of STAT1. This inhibition correlated with the redistribution of STAT1 in regions adjacent to the nucleus. At a later time point of infection, BTV was found to interfere with the activation of other key components of the JAK/STAT pathway and to induce the downregulation of JAK1 and TYK2 protein expression. Overall, our study indicates for the first time that BTV is able to interfere with the JAK/STAT pathway to modulate the IFN-I response. IMPORTANCE: Bluetongue virus (BTV) causes a severe disease in ruminants and has an important impact on the livestock economy in areas of endemicity such as Africa. The emergence of strains, such as serotype 8 in Europe in 2006, can lead to important economic losses due to commercial restrictions and prophylactic measures. It has been known for many years that BTV is a strong inducer of type I interferon (IFN-I) in vitro and in vivo in multiple cell types. However, the ability of BTV to interact with the IFN-I system remains unclear. Here, we report that BTV is able to modulate the IFN-I response by interfering with the Janus tyrosine kinase (JAK)/signal transducer and activator of transcription protein (STAT) signaling pathway. These findings contribute to knowledge of how BTV infection interferes with the host's innate immune response and becomes pathogenic. This will also be important for the design of efficacious vaccine candidates.


Subject(s)
Bluetongue virus/physiology , Bluetongue/metabolism , Interferon Type I/metabolism , Animals , Bluetongue/genetics , Bluetongue/virology , Host-Pathogen Interactions , Humans , Interferon Type I/genetics , Janus Kinase 1/genetics , Janus Kinase 1/metabolism , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , Signal Transduction
3.
Virologie (Montrouge) ; 19(4): 178-186, 2015 Aug 01.
Article in English | MEDLINE | ID: mdl-33065904

ABSTRACT

Upon viral infection, infected cells mount an antiviral response that culminates with the production of type I IFN (IFN-α/ß) and other pro-inflammatory cytokines that control the infection. Production of type I IFN occurs both in vivo and in vitro in response to Bluetongue virus (BTV), an arthropod-borne virus, but the underlying mechanisms responsible for this event remained unknown until recently. This review describes the recent advances in the identification of cellular sensors and signalling pathways involved in this process. In non-hematopoietic cells, expression of IFN-ß in response to BTV infection depends on the activation of the RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5). In contrast, induction of IFN-α/ß synthesis in sheep primary plasmacytoid dendritic cells (pDCs) required the MyD88 adaptor independently of the Toll-like receptor 7 (TLR7), as well as the kinases dsRNA-activated protein kinase (PKR) and stress-activated protein kinase (SAPK)/Jun N-terminal protein kinase (JNK). In order to counteract this antiviral response, most of viruses have elaborated mechanisms to hinder its action. This review also describes the ability of BTV to interfere with the IFN pathway and the recent findings describing the non-structural viral protein NS3 as a powerful antagonist of the host cellular response.

4.
Virologie (Montrouge) ; 19(3): 149-160, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-33065910

ABSTRACT

The concept of zoonotic viral hepatitis E has emerged a few years ago in countries where sporadic cases of hepatitis E were not associated with travel in geographical areas where the virus is endemic (tropical or subtropical regions) . Improved diagnostic methods and the awareness of clinicians helped to better assess the impact of infection by hepatitis E virus (HEV) and identify new related syndromes. Similarly, the description of chronic forms of hepatitis E in immunocompromised patients raises the question of the treatment and prevention of this disease. Recent advances in the identification of animal reservoirs of HEV have confirmed that the strains circulating in domestic and wild pigs are genetically close to strains identified in indigenous cases. Characterization of HEV infection in swine herds has identified risk factors associated to the virus spreading. In addition, the identification of HEV in the food chain or products containing pork has shown that it is a food-borne zoonosis. The arrival of recent technologies to identify new agents helped expand the family of HEV related viruses and identify potential new animal reservoirs.

5.
J Virol ; 87(14): 8241-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23658442

ABSTRACT

Upon infection with Bluetongue virus (BTV), an arthropod-borne virus, type I interferon (IFN-I) is produced in vivo and in vitro. IFN-I is essential for the establishment of an antiviral cellular response, and most if not all viruses have elaborated strategies to counteract its action. In this study, we assessed the ability of BTV to interfere with IFN-I synthesis and identified the nonstructural viral protein NS3 as an antagonist of the IFN-I system.


Subject(s)
Bluetongue virus/immunology , Immunity, Innate/immunology , Interferon Type I/antagonists & inhibitors , Signal Transduction/immunology , Viral Nonstructural Proteins/metabolism , Blotting, Western , Enzyme-Linked Immunosorbent Assay , HEK293 Cells , Humans , Immunity, Innate/drug effects , Interferon Type I/biosynthesis , Luciferases , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Viral Nonstructural Proteins/pharmacology
6.
J Virol ; 86(21): 11789-99, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22915805

ABSTRACT

Bluetongue virus (BTV), an arthropod-borne member of the Reoviridae family, is a double-stranded RNA virus that causes an economically important livestock disease that has spread across Europe in recent decades. Production of type I interferon (alpha/beta interferon [IFN-α/ß]) has been reported in vivo and in vitro upon BTV infection. However, the cellular sensors and signaling pathways involved in this process remain unknown. Here we studied the mechanisms responsible for the production of IFN-ß in response to BTV serotype 8. Upon BTV infection of A549 cells, expression of IFN-ß and other proinflammatory cytokines was strongly induced at both the protein and mRNA levels. This response appeared to be dependent on virus replication, since exposure to UV-inactivated virus failed to induce IFN-ß. We also demonstrated that BTV infection activated the transcription factors IFN regulatory factor 3 and nuclear factor κB. We investigated the role of several pattern recognition receptors in this response and showed that expression of IFN-ß was greatly reduced after small-interfering-RNA-mediated knockdown of the RNA helicase encoded by retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated gene 5 (MDA5). In contrast, silencing of MyD88, Toll-like receptor 3, or the recently described DexD/H-box helicase DDX1 sensor had no or a weak effect on IFN-ß induction, suggesting that the RIG-I-like receptor pathway is specifically engaged for BTV sensing. Moreover, we also showed that overexpression of either RIG-I or MDA5 impaired BTV expression in infected A549 cells. Overall, this indicates that RIG-I and MDA5 can both contribute to the recognition and control of BTV infection.


Subject(s)
Bluetongue virus/immunology , DEAD-box RNA Helicases/metabolism , Epithelial Cells/virology , Host-Pathogen Interactions , Interferon-beta/biosynthesis , Animals , Cell Line , DEAD Box Protein 58 , DEAD-box RNA Helicases/genetics , Gene Expression Profiling , Gene Silencing , Humans , Interferon-Induced Helicase, IFIH1 , Interferon-beta/genetics , Receptors, Immunologic
7.
Vet Res ; 44: 31, 2013 May 15.
Article in English | MEDLINE | ID: mdl-23675914

ABSTRACT

After the unexpected emergence of Bluetongue virus serotype 8 (BTV-8) in northern Europe in 2006, another arbovirus, Schmallenberg virus (SBV), emerged in Europe in 2011 causing a new economically important disease in ruminants. The virus, belonging to the Orthobunyavirus genus in the Bunyaviridae family, was first detected in Germany, in The Netherlands and in Belgium in 2011 and soon after in the United Kingdom, France, Italy, Luxembourg, Spain, Denmark and Switzerland. This review describes the current knowledge on the emergence, epidemiology, clinical signs, molecular virology and diagnosis of SBV infection.


Subject(s)
Bunyaviridae Infections/veterinary , Communicable Diseases, Emerging/veterinary , Orthobunyavirus/physiology , Ruminants , Animals , Bunyaviridae Infections/diagnosis , Bunyaviridae Infections/epidemiology , Bunyaviridae Infections/etiology , Communicable Diseases, Emerging/diagnosis , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/etiology , Europe/epidemiology , Orthobunyavirus/classification , Orthobunyavirus/genetics , Orthobunyavirus/pathogenicity
8.
Front Immunol ; 14: 1291186, 2023.
Article in English | MEDLINE | ID: mdl-38058490

ABSTRACT

Introduction: Hepatitis E virus (HEV) is a common cause of enterically transmitted acute hepatitis worldwide. The virus is transmitted by the fecal-oral route via the consumption of contaminated water supplies and is also a zoonotic foodborne pathogen. Swine are the main reservoir of zoonotic HEV. In humans, HEV infection is usually asymptomatic or causes acute hepatitis that is self-limited. However, fulminant hepatic failure and chronic cases of HEV infection can occur in some patients. In contrast, HEV infection in pigs remains asymptomatic, although the virus replicates efficiently, suggesting that swine are able to control the virus pathogenesis. Upon viral infection, IFN is secreted and activates cellular pathways leading to the expression of many IFN-stimulated genes (ISGs). ISGs can restrict the replication of specific viruses and establish an antiviral state within infected and neighboring cells. Methods: In this study, we used PCR arrays to determine the expression level of up to 168 ISGs and other IFN-related genes in the liver tissues of pigs infected with zoonotic HEV-3c and HEV-3f and in human bipotent liver HepaRG cells persistently infected with HEV-3f. Results and discussion: The expression of 12 and 25 ISGs was found to be up-regulated in infected swine livers and HepaRG cells, respectively. The expression of CXCL10, IFIT2, MX2, OASL and OAS2 was up-regulated in both species. Increased expression of IFI16 mRNA was also found in swine liver tissues. This study contributes to the identification of potential ISGs that could play a role in the control or persistence of HEV infection.


Subject(s)
Hepatitis E virus , Hepatitis E , Humans , Animals , Swine , Hepatitis E virus/genetics , Interferons/genetics , Hepatitis E/genetics , Hepatocytes
9.
J Gen Virol ; 93(Pt 9): 1876-1886, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22622330

ABSTRACT

Vaccinia virus (VACV) spreads across cell monolayers fourfold faster than predicted from its replication kinetics. Early after infection, infected cells repulse some superinfecting extracellular enveloped virus (EEV) particles by the formation of actin tails from the cell surface, thereby causing accelerated spread to uninfected cells. This strategy requires the expression of two viral proteins, A33 and A36, on the surface of infected cells and upon contact with EEV this complex induces actin polymerization. Here we have studied this phenomenon further and investigated whether A33 and A36 expression in cell lines causes an increase in VACV plaque size, whether these proteins are able to block superinfection by EEV, and which protein(s) on the EEV surface are required to initiate the formation of actin tails from infected cells. Data presented show that VACV plaque size was not increased by expression of A33 and A36, and these proteins did not block entry of the majority of EEV binding to these cells. In contrast, expression of proteins A56 and K2 inhibited entry of both EEV and intracellular mature virus. Lastly, VACV protein B5 was required on EEV to induce the formation of actin tails at the surface of cells expressing A33 and A36, and B5 short consensus repeat 4 is critical for this induction.


Subject(s)
Cell Membrane/virology , Superinfection/virology , Vaccinia virus/physiology , Vaccinia/virology , Viral Matrix Proteins/metabolism , Virion/physiology , Actins/metabolism , Cell Membrane/metabolism , HeLa Cells , Humans , Vaccinia/metabolism , Vaccinia virus/genetics , Viral Matrix Proteins/genetics , Viral Plaque Assay , Virion/genetics , Virus Internalization
10.
Transbound Emerg Dis ; 69(5): e2706-e2718, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35689821

ABSTRACT

Hepatitis E virus (HEV) infection can be acute and benign or evolve to chronic hepatitis with rapid progression toward cirrhosis or liver failure in humans. Hence, hepatitis E (HE) disease is a major public health concern. In countries where pig populations are highly contaminated with HEV, human cases of HE are mainly foodborne, occurring frequently after consumption of raw or undercooked pork products or liver. Among factors associated to the presence of HEV in pork livers from intensive rearing systems, early slaughter (≤6 months) seems to be major. In Corsica, local pigs are raised in extensive farming systems and slaughtered after 12 months. To evaluate if slaughter of pigs over 12 months reduces the risk of HEV presence in livers, 1197 liver samples were randomly collected in 2 Corsican slaughterhouses. Presence of HEV RNA was detected in liver and HEV seroprevalence was determined in paired serum. The sampling included 1083 livers from animals between 12 and 48 months and 114 livers from animals <12 months. The samples were predominantly from semi-extensive and extensive farms (n = 1154). Estimated HEV seroprevalence was high, that is, >88%, and HEV RNA prevalence in adult pig livers (>12 months old) was low, that is, 0.18%. However, in livers from younger animals (<12 months), including piglets below 6 months old, 5.3% (6/114) of the samples were positive for HEV RNA. Sequences recovered from positive livers belonged to HEV genotype 3c and 3f. The presence of infectious HEV was confirmed in two livers by the detection of HEV replication in HepaRG cell cultures. Thus, this study demonstrates the low prevalence of HEV in livers of pigs over 12 months, even in farms with high HEV circulation. This observation may open new perspectives on the preferential use of livers from animals older than 12 months in raw pork liver products.


Subject(s)
Hepatitis E virus , Hepatitis E , Swine Diseases , Animals , Hepatitis E/epidemiology , Hepatitis E/veterinary , Hepatitis E virus/genetics , Liver , Prevalence , RNA , RNA, Viral/genetics , Seroepidemiologic Studies , Swine , Swine Diseases/epidemiology
11.
Viruses ; 13(3)2021 03 04.
Article in English | MEDLINE | ID: mdl-33806591

ABSTRACT

Hepatitis E virus (HEV) is considered as an emerging global health problem. In most cases, hepatitis E is a self-limiting disease and the virus is cleared spontaneously without the need of antiviral therapy. However, immunocompromised individuals can develop chronic infection and liver fibrosis that can progress rapidly to cirrhosis and liver failure. The lack of efficient and relevant cell culture system and animal models has limited our understanding of the biology of HEV and the development of effective drugs for chronic cases. In the present study, we developed a model of persistent HEV infection in human hepatocytes in which HEV replicates efficiently. This HEV cell culture system is based on differentiated HepaRG cells infected with an isolate of HEV-3 derived from a patient suffering from acute hepatitis E. Efficient replication was maintained for several weeks to several months as well as after seven successive passages on HepaRG naïve cells. Moreover, after six passages onto HepaRG, we found that the virus was still infectious after oral inoculation into pigs. We also showed that ribavirin had an inhibitory effect on HEV replication in HepaRG. In conclusion, this system represents a relevant and efficient in vitro model of HEV replication that could be useful to study HEV biology and identify effective antiviral drugs against chronic HEV infection.


Subject(s)
Cell Culture Techniques/methods , Hepatitis E virus/growth & development , Hepatitis E/virology , Hepatocytes/virology , Animals , Cell Line , Hepatocytes/cytology , Humans , Swine , Virus Replication
12.
J Gen Virol ; 91(Pt 11): 2677-86, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20631090

ABSTRACT

The positive-stranded RNA genome of classical swine fever virus (CSFV) encodes 12 known proteins. The first protein to be translated is the N-terminal protease (N(pro)). N(pro) helps evade the innate interferon response by targeting interferon regulatory factor-3 for proteasomal degradation and also participates in the evasion of dsRNA-induced apoptosis. To elucidate the mechanisms by which N(pro) functions, we performed a yeast two-hybrid screen in which the anti-apoptotic protein HAX-1 was identified. The N(pro)-HAX-1 interaction was confirmed using co-precipitation assays. A dramatic redistribution of both N(pro) and HAX-1 was observed in co-transfected cells, as well as in transfected cells infected with wild-type CSFV, but not in cells infected with an N(pro)-deleted CSFV strain.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Classical Swine Fever Virus/pathogenicity , Endopeptidases/metabolism , Host-Pathogen Interactions , Protein Interaction Mapping , Viral Proteins/metabolism , Animals , Cell Line , Humans , Immunoprecipitation , Protein Binding , Swine , Two-Hybrid System Techniques
15.
Viruses ; 10(12)2018 12 18.
Article in English | MEDLINE | ID: mdl-30567349

ABSTRACT

Hepatitis E virus (HEV) is responsible for large waterborne epidemics of hepatitis in endemic countries and is an emerging zoonotic pathogen worldwide. In endemic regions, HEV-1 or HEV-2 genotypes are frequently associated with fulminant hepatitis in pregnant women, while with zoonotic HEV (HEV-3 and HEV-4), chronic cases of hepatitis and severe neurological disorders are reported. Hence, it is important to characterize the interactions between HEV and its host. Here, we investigated the ability of the nonstructural polyprotein encoded by the first open reading frame (ORF1) of HEV to modulate the host early antiviral response and, in particular, the type I interferon (IFN-I) system. We found that the amino-terminal region of HEV-3 ORF1 (MetYPCP), containing a putative methyltransferase (Met) and a papain-like cysteine protease (PCP) functional domain, inhibited IFN-stimulated response element (ISRE) promoter activation and the expression of several IFN-stimulated genes (ISGs) in response to IFN-I. We showed that the MetYPCP domain interfered with the Janus kinase (JAK)/signal transducer and activator of the transcription protein (STAT) signalling pathway by inhibiting STAT1 nuclear translocation and phosphorylation after IFN-I treatment. In contrast, MetYPCP had no effect on STAT2 phosphorylation and a limited impact on the activation of the JAK/STAT pathway after IFN-II stimulation. This inhibitory function seemed to be genotype-dependent, as MetYPCP from HEV-1 had no significant effect on the JAK/STAT pathway. Overall, this study provides evidence that the predicted MetYPCP domain of HEV ORF1 antagonises STAT1 activation to modulate the IFN response.


Subject(s)
Cysteine Proteases/genetics , Hepatitis E virus/genetics , Interferon Type I/immunology , Methyltransferases/genetics , Open Reading Frames/genetics , HEK293 Cells , Hepatitis E virus/drug effects , Humans , Immunity, Innate , Interferon Type I/pharmacology , Janus Kinase 1/genetics , Phosphorylation , STAT Transcription Factors/genetics , Signal Transduction , Translocation, Genetic
16.
BMC Biotechnol ; 7: 93, 2007 Dec 20.
Article in English | MEDLINE | ID: mdl-18096051

ABSTRACT

BACKGROUND: HERG potassium channel blockade is the major cause for drug-induced long QT syndrome, which sometimes cause cardiac disrhythmias and sudden death. There is a strong interest in the pharmaceutical industry to develop high quality medium to high-throughput assays for detecting compounds with potential cardiac liability at the earliest stages of drug development. Cultivation of cells at lower temperature has been used to improve the folding and membrane localization of trafficking defective hERG mutant proteins. The objective of this study was to investigate the effect of lower temperature maintenance on wild type hERG expression and assay performance. RESULTS: Wild type hERG was stably expressed in CHO-K1 cells, with the majority of channel protein being located in the cytoplasm, but relatively little on the cell surface. Expression at both locations was increased several-fold by cultivation at lower growth temperatures. Intracellular hERG protein levels were highest at 27 degrees C and this correlated with maximal 3H-dofetilide binding activity. In contrast, the expression of functionally active cell surface-associated hERG measured by patch clamp electrophysiology was optimal at 30 degrees C. The majority of the cytoplasmic hERG protein was associated with the membranes of cytoplasmic vesicles, which markedly increased in quantity and size at lower temperatures or in the presence of the Ca2+-ATPase inhibitor, thapsigargin. Incubation with the endocytic trafficking blocker, nocodazole, led to an increase in hERG activity at 37 degrees C, but not at 30 degrees C. CONCLUSION: Our results are consistent with the concept that maintenance of cells at reduced temperature can be used to boost the functional expression of difficult-to-express membrane proteins and improve the quality of assays for medium to high-throughput compound screening. In addition, these results shed some light on the trafficking of hERG protein under these growth conditions.


Subject(s)
Cell Culture Techniques/methods , Ether-A-Go-Go Potassium Channels/biosynthesis , Protein Transport , Animals , Biological Transport, Active/drug effects , CHO Cells , Ca(2+) Mg(2+)-ATPase/drug effects , Cricetinae , Cricetulus , Ether-A-Go-Go Potassium Channels/drug effects , Humans , Membrane Proteins , Nocodazole/pharmacology , Phenethylamines/pharmacology , Potassium Channel Blockers , Recombinant Proteins , Sulfonamides/pharmacology , Temperature , Thapsigargin/pharmacology , Transport Vesicles/drug effects , Up-Regulation
19.
Viruses ; 8(10)2016 10 03.
Article in English | MEDLINE | ID: mdl-27706110

ABSTRACT

During the past ten years, several new hepatitis E viruses (HEVs) have been identified in various animal species. In parallel, the number of reports of autochthonous hepatitis E in Western countries has increased as well, raising the question of what role these possible animal reservoirs play in human infections. The aim of this review is to present the recent discoveries of animal HEVs and their classification within the Hepeviridae family, their zoonotic and species barrier crossing potential, and possible use as models to study hepatitis E pathogenesis. Lastly, this review describes the transmission pathways identified from animal sources.


Subject(s)
Disease Reservoirs , Disease Transmission, Infectious , Hepatitis E virus/classification , Hepatitis E/transmission , Hepatitis E/virology , Zoonoses/transmission , Zoonoses/virology , Animals , Hepatitis E virus/isolation & purification , Humans
SELECTION OF CITATIONS
SEARCH DETAIL